The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Significant Disparities in Access to Novel Agents For Patients With Melanoma

Lidija Kandolf Sekulovic, MD, PhD
Published Online: 6:48 PM, Sun October 9, 2016

Lidija Kandolf Sekulovic, MD, PhD, associate professor of Dermatology, Military Medical Academy in Belgrade, Serbia, discusses a recently published survey during an interview at the 2016 ESMO Congress. The survey found that several thousand patients with metastatic melanoma in Europe do not have access to new, life-saving agents in this field.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.